125 related articles for article (PubMed ID: 32839774)
1. Development of a high-throughput homogeneous AlphaLISA drug screening assay for the detection of SARS-CoV-2 Nucleocapsid.
Gorshkov K; Chen CZ; de la Torre JC; Martinez-Sobrido L; Moran T; Zheng W
bioRxiv; 2020 Aug; ():. PubMed ID: 32839774
[TBL] [Abstract][Full Text] [Related]
2. Development of a High-Throughput Homogeneous AlphaLISA Drug Screening Assay for the Detection of SARS-CoV-2 Nucleocapsid.
Gorshkov K; Chen CZ; Xu M; Carlos de la Torre J; Martinez-Sobrido L; Moran T; Zheng W
ACS Pharmacol Transl Sci; 2020 Dec; 3(6):1233-1241. PubMed ID: 33330840
[TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 Nucleocapsid Protein TR-FRET Assay Amenable to High Throughput Screening.
Gorshkov K; Morales Vasquez D; Chiem K; Ye C; Nguyen Tran B; Carlos de la Torre J; Moran T; Chen CZ; Martinez-Sobrido L; Zheng W
ACS Pharmacol Transl Sci; 2022 Jan; 5(1):8-19. PubMed ID: 35036857
[TBL] [Abstract][Full Text] [Related]
4. High-throughput isolation of SARS-CoV-2 nucleocapsid antibodies for improved antigen detection.
Fujisawa M; Adachi Y; Onodera T; Shiwa-Sudo N; Iwata-Yoshikawa N; Nagata N; Suzuki T; Takeoka S; Takahashi Y
Biochem Biophys Res Commun; 2023 Sep; 673():114-120. PubMed ID: 37379800
[TBL] [Abstract][Full Text] [Related]
5. A SARS-CoV-2 nucleocapsid protein TR-FRET assay amenable to high-throughput screening.
Gorshkov K; Vasquez DM; Chiem K; Ye C; Tran BN; de la Torre JC; Moran T; Chen CZ; Martinez-Sobrido L; Zheng W
bioRxiv; 2021 Jul; ():. PubMed ID: 34268508
[TBL] [Abstract][Full Text] [Related]
6. A Generic, Scalable, and Rapid Time-Resolved Förster Resonance Energy Transfer-Based Assay for Antigen Detection-SARS-CoV-2 as a Proof of Concept.
Rusanen J; Kareinen L; Szirovicza L; Uğurlu H; Levanov L; Jääskeläinen A; Ahava M; Kurkela S; Saksela K; Hedman K; Vapalahti O; Hepojoki J
mBio; 2021 May; 12(3):. PubMed ID: 34006662
[TBL] [Abstract][Full Text] [Related]
7. Rapid Biosensor of SARS-CoV-2 Using Specific Monoclonal Antibodies Recognizing Conserved Nucleocapsid Protein Epitopes.
Lee JH; Jung Y; Lee SK; Kim J; Lee CS; Kim S; Lee JS; Kim NH; Kim HG
Viruses; 2022 Jan; 14(2):. PubMed ID: 35215848
[TBL] [Abstract][Full Text] [Related]
8. A Simplified Quantitative Real-Time PCR Assay for Monitoring SARS-CoV-2 Growth in Cell Culture.
Shema Mugisha C; Vuong HR; Puray-Chavez M; Bailey AL; Fox JM; Chen RE; Wessel AW; Scott JM; Harastani HH; Boon ACM; Shin H; Kutluay SB
mSphere; 2020 Sep; 5(5):. PubMed ID: 32878932
[TBL] [Abstract][Full Text] [Related]
9. N-terminally truncated nucleocapsid protein of SARS-CoV-2 as a better serological marker than whole nucleocapsid protein in evaluating the immunogenicity of inactivated SARS-CoV-2.
Yue L; Cao H; Xie T; Long R; Li H; Yang T; Yan M; Xie Z
J Med Virol; 2021 Mar; 93(3):1732-1738. PubMed ID: 32965677
[TBL] [Abstract][Full Text] [Related]
10. Smartphone-Based High-Throughput Fiber-Integrated Immunosensing System for Point-of-Care Testing of the SARS-CoV-2 Nucleocapsid Protein.
Wu Z; Wang C; Liu B; Liang C; Lu J; Li J; Tang X; Li C; Li T
ACS Sens; 2022 Jul; 7(7):1985-1995. PubMed ID: 35766020
[TBL] [Abstract][Full Text] [Related]
11. Development of magnetic particle-based chemiluminescence immunoassay for measurement of SARS-CoV-2 nucleocapsid protein.
Xu Y; Xia C; Zeng X; Qiu Y; Liao M; Jiang Q; Quan M; Liu R
J Virol Methods; 2022 Apr; 302():114486. PubMed ID: 35108595
[TBL] [Abstract][Full Text] [Related]
12. Rapid in vitro assays for screening neutralizing antibodies and antivirals against SARS-CoV-2.
Park JG; Oladunni FS; Chiem K; Ye C; Pipenbrink M; Moran T; Walter MR; Kobie J; Martinez-Sobrido L
J Virol Methods; 2021 Jan; 287():113995. PubMed ID: 33068703
[TBL] [Abstract][Full Text] [Related]
13. The spike-ACE2 binding assay: An in vitro platform for evaluating vaccination efficacy and for screening SARS-CoV-2 inhibitors and neutralizing antibodies.
Zhang S; Gao C; Das T; Luo S; Tang H; Yao X; Cho CY; Lv J; Maravillas K; Jones V; Chen X; Huang R
J Immunol Methods; 2022 Apr; 503():113244. PubMed ID: 35218866
[TBL] [Abstract][Full Text] [Related]
14. Generation and Characterization of recombinant SARS-CoV-2 expressing reporter genes.
Chiem K; Morales Vasquez D; Park JG; Platt RN; Anderson T; Walter MR; Kobie JJ; Ye C; Martinez-Sobrido L
J Virol; 2021 Mar; 95(7):. PubMed ID: 33431557
[TBL] [Abstract][Full Text] [Related]
15. Development of a Fluorescence-Based, High-Throughput SARS-CoV-2 3CL
Froggatt HM; Heaton BE; Heaton NS
J Virol; 2020 Oct; 94(22):. PubMed ID: 32843534
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal Antibodies against Nucleocapsid Protein of SARS-CoV-2 Variants for Detection of COVID-19.
Lu RM; Ko SH; Chen WY; Chang YL; Lin HT; Wu HC
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830291
[TBL] [Abstract][Full Text] [Related]
17. Diagnostics of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) nucleocapsid antigen using chicken immunoglobulin Y.
Palaniyappan A; Das D; Kammila S; Suresh MR; Sunwoo HH
Poult Sci; 2012 Mar; 91(3):636-42. PubMed ID: 22334738
[TBL] [Abstract][Full Text] [Related]
18. Development of Patient-Derived Human Monoclonal Antibodies Against Nucleocapsid Protein of Severe Acute Respiratory Syndrome Coronavirus 2 for Coronavirus Disease 2019 Diagnosis.
Zhang L; Zheng B; Gao X; Zhang L; Pan H; Qiao Y; Suo G; Zhu F
Front Immunol; 2020; 11():595970. PubMed ID: 33281824
[TBL] [Abstract][Full Text] [Related]
19. Development of nucleocapsid-specific monoclonal antibodies for SARS-CoV-2 and their ELISA diagnostics on an automatic microfluidic device.
Yang J; Phan VM; Heo CK; Nguyen HV; Lim WH; Cho EW; Poo H; Seo TS
Sens Actuators B Chem; 2023 Apr; 380():133331. PubMed ID: 36644652
[TBL] [Abstract][Full Text] [Related]
20. Biochemical and immunological studies of nucleocapsid proteins of severe acute respiratory syndrome and 229E human coronaviruses.
Tang TK; Wu MP; Chen ST; Hou MH; Hong MH; Pan FM; Yu HM; Chen JH; Yao CW; Wang AH
Proteomics; 2005 Mar; 5(4):925-37. PubMed ID: 15759315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
